Serum hepatocyte growth factor (HGF) levels predict the outcomes in hepatectomized patients with postoperative hyperbilirubinemia

International Hepatology Communications

Volumn 6, Issue 6, 1997, Pages 294-299

  Ueno, Shinichi ^a   Tanabe, Gen ^a   Kawaida, Kouichi ^a   Hamanoue, Masahiro ^a   Mitsue, Shinji ^a   Ogura, Yoshito ^a   Yoshidome, Shinrou ^a   Nuruki, Kensuke ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

hepatectomy; hepatocyte growth factor; hyperbilirubinemia

Indexed keywords

BILIRUBIN; SCATTER FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; LIVER FAILURE; LIVER SURGERY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031106288     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(97)00359-9     Document Type: Article

References (11)

1. [1] Eiseman B, Koep L. Postoperative jaundice and hepatic failure. In: Calne RY, editor. Liver Surgery with Operative Color Illustrations. Pauda (Italy): Piccin Medical Books. 1982: 219-228.
2. [2] Kawaida K, Tanabe G, Kurita K et al. Indication and effect of hemopurification for hyperbilirubinamia after hepatectomy for hepatocellular carcinoma. Jpn J Gastroenterol Surg 1993; 26: 1227-1232.
3. [3] Tsubouchi H, Niitani Y, Hirono S et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13: 1-5.
4. [4] Tomiya T, Nagoshi S and Fujiwara K. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992; 15: 1-4.
5. [5] Shiota G, Okano J, Kawasaki H, Kawamoto T and Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 106-112.
6. [6] Ogasawara K, Hata Y, Une Y et al. Preoperative and postoperative variations of human hepatocyte growth factor (hHGF) in hepatectomized patients. Jpn J Surg 1994; 95: 521-527.
7. [7] Mutou Y, Kawai T, Satou S et al. Clinical significance of human hepatocyte growth factor in sera of patients with various liver diseases (a large scale study from 19 institutions in Japan). Kan Tan Sui 1992; 25: 541-549.
8. [8] Schmid M, Hefti ML, Gattiker R, Kistler H and Senning A. Benign postoperative intrahepatic cholestasis. N Eng J Med 965; 272: 545-550.
9. [9] Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13: 743-749.
10. [10] Sakon M, Monden M, Goth M et al. Hepatocyte growth factor concentrations after liver resection. Lancet 1992; 339: 818.
11. [11] Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and non-hepatectomized surgical patients. Gastroenterology 1992; 103: 1621-1624.